Prevalence, correlates and comorbidity of DSM-IV Cannabis Use and Cannabis Use Disorders in Australia.
paper
Cited
Public
Unavailable
- Authors
- Teesson, Maree; Slade, Tim; Swift, Wendy; Mills, Katherine; Memedovic, Sonja; Mewton, Louise; Grove, Rachel; Newton, Nicola; Hall, Wayne
- Year
- 2012
- Journal
- The Australian and New Zealand journal of psychiatry
- PMID
- 22984111
- DOI
- 10.1177/0004867412460591
OBJECTIVE: To report nationally representative findings on the prevalence, correlates, psychiatric comorbidity and treatment of DSM-IV Cannabis Use and Cannabis Use Disorders in Australia. METHOD: The 2007 National Survey of Mental Health and Wellbeing was a nationally representative household survey of 8841 Australians (16-85 years) that assessed symptoms of the most prevalent DSM-IV mental disorders. RESULTS: Prevalence of lifetime and 12-month cannabis use was 18% and 6%; prevalence of lifetime and 12-month cannabis use disorder was 6% and 1%. The conditional prevalence (proportion of ever users who met criteria for a disorder) of lifetime and 12-month cannabis use disorder was 32.2% and 14.3%. Current cannabis use disorders were more common in males (OR 2.0) and younger users (OR 4.6). Strong associations were observed between current cannabis use disorders and alcohol use disorders (OR 3.6) and current affective disorders (OR 3.0). Only 36.2% of those with current cannabis use disorders sought any treatment. CONCLUSIONS: The prevalence of cannabis use disorders in the Australian population is comparable with that in the USA. Current cannabis use disorders are highly concentrated in young Australians who have high levels of comorbidity. The low rates of treatment seeking warrant attention in treatment and prevention strategies.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Cannabis-related facial trauma: a 10-year review of facial trauma in Victoria, Australia. | Tran V et al. | — | 2025 | → |
| Cannabis use and its impact on respiratory physiology and lung cancer risk: Mechanistic and epidemiological insights (Review). | Georgakopoulou VE et al. | — | 2025 | → |
| Prevalence of Cannabis Use Disorder: A Meta-Analysis of Population Surveys. | Boness CL et al. | — | 2025 | → |
| A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol. | Bhardwaj AK et al. | — | 2024 | → |
| Mental ill-health and substance use among sexuality diverse adolescents: The critical role of school climate and teacher self-efficacy. | Bailey S et al. | — | 2024 | → |
| Prevalence and correlates of severe problematic cannabis use: analysis of a population-based survey in Jamaica. | Lalwani K et al. | — | 2024 | → |
| A Prospective Comparison of Bipolar I and II Subjects with and without Comorbid Cannabis Use Disorders from the COGA Dataset. | Preuss UW et al. | — | 2023 | → |
| A randomized controlled trial of brief intervention for patients with cannabis use disorder. | Shekhawat AS et al. | — | 2023 | → |
| Risk of readmission among individuals with cannabis use disorder during a 15-year cohort study: the impact of socio-economic factors and psychiatric comorbidity. | Rabiee R et al. | — | 2023 | → |
| Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence. | Kuhns L et al. | — | 2022 | → |
| Clinical management of cannabis withdrawal. | Connor JP et al. | — | 2022 | → |
| Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III). | Browne KC et al. | — | 2022 | → |
| Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition. | Mills L et al. | — | 2022 | → |
| A systematic review and meta-analysis of sex differences in cannabis use disorder amongst people with comorbid mental illness. | Kozak K et al. | — | 2021 | → |
| Cannabis use and cannabis use disorder. | Connor JP et al. | — | 2021 | → |
| CANreduce 2.0 Adherence-Focused Guidance for Internet Self-Help Among Cannabis Users: Three-Arm Randomized Controlled Trial. | Baumgartner C et al. | — | 2021 | → |
| Comorbid Cannabis Use Disorder with Major Depression and Generalized Anxiety Disorder: A Systematic Review with Meta-analysis of Nationally Representative Epidemiological Surveys. | Onaemo VN et al. | — | 2021 | → |
| Past Year Cannabis Use Among Norwegian Adolescents: Time Trends Based on the Ungdata Surveys 2010-2019. | Heradstveit O et al. | — | 2021 | → |
| Prevalence and correlates of non-daily and daily cannabis use among persons 15 years and older in South Africa: results of a national survey in 2017. | Ramlagan S et al. | — | 2021 | → |
| Attentional bias, craving and cannabis use in an inpatient sample of adolescents and young adults diagnosed with cannabis use disorder: The moderating role of cognitive control. | Van Kampen AD et al. | — | 2020 | → |
| Cannabis-Related Impairment and Social Anxiety: The Role of Use to Manage Negative and Positive Affect in Social Situations. | Walukevich-Dienst K et al. | — | 2020 | → |
| <i>DRD4, DRD2, DAT1,</i> and <i>ANKK1</i> Genes Polymorphisms in Patients with Dual Diagnosis of Polysubstance Addictions. | Masiak J et al. | — | 2020 | → |
| Is there a relationship between cannabis use problems, emotion dysregulation, and mental health problems among adults with chronic pain? | Orr MF et al. | — | 2020 | → |
| Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990-2019: Systematic review and meta-analysis. | Hunt GE et al. | — | 2020 | → |
| An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use. | Budney AJ et al. | — | 2019 | → |
| Determining Risks for Cannabis Use Disorder in the Face of Changing Legal Policies. | Taylor M et al. | — | 2019 | → |
| Integrated cognitive behavioral therapy for comorbid cannabis use and anxiety disorders: A pilot randomized controlled trial. | Buckner JD et al. | — | 2019 | → |
| Measuring Unmet Demand for Alcohol and Other Drug Treatment: The Application of an Australian Population-Based Planning Model. | Ritter A et al. | — | 2019 | → |
| Thinking Beyond Legalization: The Case for Expanding Evidence-Based Options for Cannabis Use Disorder Treatment in Canada. | Jutras-Aswad D et al. | — | 2019 | → |
| Cannabis regulatory science: risk-benefit considerations for mental disorders. | Borodovsky JT et al. | — | 2018 | → |
| Cannabis Use, Lung Cancer, and Related Issues. | Jett J et al. | — | 2018 | → |
| DSM-5 cannabis use disorder in the National Epidemiologic Survey on Alcohol and Related Conditions-III: Gender-specific profiles. | Kerridge BT et al. | — | 2018 | → |
| Nineteen and Up study (19Up): understanding pathways to mental health disorders in young Australian twins. | Couvy-Duchesne B et al. | — | 2018 | → |
| The efficacy of computerized interventions to reduce cannabis use: A systematic review and meta-analysis. | Olmos A et al. | — | 2018 | → |
| Universal prevention of alcohol and drug use: An overview of reviews in an Australian context. | Mewton L et al. | — | 2018 | → |
| Addiction and Mental Health Across the Lifespan: An Overview of Some Contemporary Issues. | Cleary M et al. | — | 2017 | → |
| Cannabis use during treatment for alcohol use disorders predicts alcohol treatment outcomes. | Subbaraman MS et al. | — | 2017 | → |
| Past year cannabis use and problematic cannabis use among adults by ethnicity in Ontario. | Tuck A et al. | — | 2017 | → |
| Substance use disorders comorbid with mood and anxiety disorders in the Australian general population. | Prior K et al. | — | 2017 | → |
| Cannabis Use in Adolescence and Young Adulthood: A Review of Findings from the Victorian Adolescent Health Cohort Study. | Coffey C et al. | — | 2016 | → |
| Comorbidity of bipolar and substance use disorders in national surveys of general populations, 1990-2015: Systematic review and meta-analysis. | Hunt GE et al. | — | 2016 | → |
| Integrated Exposure-Based Therapy for Co-Occurring Post Traumatic Stress Disorder (PTSD) and Substance Dependence: Predictors of Change in PTSD Symptom Severity. | Mills KL et al. | — | 2016 | → |
| Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III. | Hasin DS et al. | — | 2016 | → |
| Psychosocial interventions for cannabis use disorder. | Gates PJ et al. | — | 2016 | → |
| Cannabis: the never-ending, nefarious nepenthe of the 21st century: what should the clinician know? | Greydanus DE et al. | — | 2015 | → |
| No additive effect of cannabis on cognition in schizophrenia. | Power BD et al. | — | 2015 | → |
| Cannabis use and anxiety: is stress the missing piece of the puzzle? | Temple EC et al. | — | 2014 | → |
| Cost benefit analysis of two policy options for cannabis: status quo and legalisation. | Shanahan M et al. | — | 2014 | → |
| Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile. | Swift W et al. | — | 2013 | → |
| Cannabis dependence, cognitive control and attentional bias for cannabis words. | Cousijn J et al. | — | 2013 | → |
| Changes in cannabis use among young people: impact on mental health. | Copeland J et al. | — | 2013 | → |
| Factors influencing mortality among alcohol and drug treatment clients in Victoria, Australia: the role of demographic and substance use characteristics. | Lloyd B et al. | — | 2013 | → |
| Health outcomes associated with long-term regular cannabis and tobacco smoking. | Rooke SE et al. | — | 2013 | → |
| Marijuana: current concepts(†). | Greydanus DE et al. | — | 2013 | → |
| Drugs, sex and neurobiology. | Boyce P | — | 2012 | → |